You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The award covers the first of five years for running and enhancing the All of Us Participant Technology Systems Center.
Mount Sinai bioinformaticians have quickly pivoted from Lyme disease research to building a reference tool for researchers pursuing COVID therapies.
The OpenNotes movement is encouraging experimentation as some health systems start making complete genomic reports available to patients the moment the lab signs off.
A study group eager to learn about genetic testing online was not won over by videos produced by academics without communication expertise.
A new partnership and licensing agreement will help the research institute aggregate genotype and phenotype data for the NIH-funded PreCISE Network asthma program.
Proposals from two HHS agencies look to encourage patient access to data and interoperability in research and clinical practice, including Sync for Genes.
This embargo-free strategy represents "an entirely new way of doing research" into rare pediatric cancers, where time is of the essence.
HudsonAlpha's Genome Gateway collects family histories and facilitates secure communication between patients, clinicians, and researchers.
In development for several years, PORTIN is now being deployed as a single point of reference for all genotype and phenotype data at Bayer's research sites.
The system relies on the use of scannable safety code cards containing patient data, along with a web portal and automated analysis tools that deliver customized diagnostic reports.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.